Daniel E. Leisman

2.5k total citations · 1 hit paper
31 papers, 1.1k citations indexed

About

Daniel E. Leisman is a scholar working on Epidemiology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Daniel E. Leisman has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 8 papers in Surgery and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Daniel E. Leisman's work include Sepsis Diagnosis and Treatment (18 papers), Hemodynamic Monitoring and Therapy (6 papers) and Blood Pressure and Hypertension Studies (5 papers). Daniel E. Leisman is often cited by papers focused on Sepsis Diagnosis and Treatment (18 papers), Hemodynamic Monitoring and Therapy (6 papers) and Blood Pressure and Hypertension Studies (5 papers). Daniel E. Leisman collaborates with scholars based in United States, Australia and United Kingdom. Daniel E. Leisman's co-authors include Matthew Taylor, Clifford S. Deutschman, Pratik Sinha, Alexandre V. Hirayama, Michael O. Harhay, Lukas Ronner, Carolyn S. Calfee, Matthieu Legrand, Cameron J. Turtle and Rachel Pinotti and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Kidney International and Critical Care Medicine.

In The Last Decade

Daniel E. Leisman

30 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes

2020 551 citations Daniel E. Leisman, Lukas Ronner et al. The Lancet Respiratory Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel E. Leisman United States	14	433	416	251	207	202	31	1.1k
Julio Badié France	15	381 0.9×	266 0.6×	233 0.9×	381 1.8×	300 1.5×	25	1.2k
Edward J. Schenck United States	20	380 0.9×	265 0.6×	201 0.8×	120 0.6×	204 1.0×	59	1.2k
Kevin Roedl Germany	21	513 1.2×	180 0.4×	107 0.4×	234 1.1×	184 0.9×	80	1.2k
Kevin Bryan Lo United States	21	222 0.5×	492 1.2×	273 1.1×	219 1.1×	99 0.5×	121	1.5k
Roelie M. Wösten‐van Asperen Netherlands	18	250 0.6×	242 0.6×	107 0.4×	152 0.7×	95 0.5×	43	1.0k
Ling Sang China	16	310 0.7×	737 1.8×	320 1.3×	103 0.5×	161 0.8×	50	1.4k
Guillaume Marcotte France	18	434 1.0×	207 0.5×	189 0.8×	218 1.1×	637 3.2×	50	1.4k
Carlo Nozzoli Italy	19	292 0.7×	252 0.6×	137 0.5×	112 0.5×	105 0.5×	84	1.1k
Songqiao Liu China	21	265 0.6×	207 0.5×	133 0.5×	216 1.0×	370 1.8×	92	1.4k
Jihad Mallat France	22	577 1.3×	204 0.5×	156 0.6×	552 2.7×	302 1.5×	96	1.5k

Countries citing papers authored by Daniel E. Leisman

Since Specialization

Citations

This map shows the geographic impact of Daniel E. Leisman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Leisman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Leisman more than expected).

Fields of papers citing papers by Daniel E. Leisman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel E. Leisman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Leisman. The network helps show where Daniel E. Leisman may publish in the future.

Co-authorship network of co-authors of Daniel E. Leisman

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel E. Leisman. A scholar is included among the top collaborators of Daniel E. Leisman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel E. Leisman. Daniel E. Leisman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leisman, Daniel E., Patrick M. Wieruszewski, Laurence W. Busse, et al.. (2025). An index of the initial blood pressure response to angiotensin II treatment and its association with clinical outcomes in vasodilatory shock. Critical Care. 29(1). 81–81.

Mastroianni, Fiore, et al.. (2024). Kidney Blood Flow and Renin-Angiotensin-Aldosterone System Measurements Associated With Kidney and Cardiovascular Dysfunction in Pediatric Shock. Critical Care Explorations. 6(8). e1134–e1134. 1 indexed citations

Nedeljkovic-Kurepa, Ana, et al.. (2024). M1 cholinergic signaling in the brain modulates cytokine levels and splenic cell sub-phenotypes following cecal ligation and puncture. Molecular Medicine. 30(1). 22–22. 4 indexed citations

Leisman, Daniel E., Damian Handisides, Laurence W. Busse, et al.. (2024). ACE inhibitors and angiotensin receptor blockers differentially alter the response to angiotensin II treatment in vasodilatory shock. Critical Care. 28(1). 130–130. 12 indexed citations

Schaich, Christopher L., et al.. (2024). Dysfunction of the renin-angiotensin-aldosterone system in human septic shock. Peptides. 176. 171201–171201. 5 indexed citations

Leisman, Daniel E., Damian Handisides, Lakhmir S. Chawla, et al.. (2023). Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shock. Annals of Intensive Care. 13(1). 128–128. 10 indexed citations

Leisman, Daniel E., Lukas Ronner, Rachel Pinotti, et al.. (2020). Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes. The Lancet Respiratory Medicine. 8(12). 1233–1244. 551 indexed citations breakdown →

Kelley, Benjamin V., Zeinab Mamouei, Nicolas Cevallos, et al.. (2020). Inhibition of Angiotensin Converting Enzyme Impairs Anti-staphylococcal Immune Function in a Preclinical Model of Implant Infection. Frontiers in Immunology. 11. 1919–1919. 6 indexed citations

Leisman, Daniel E., Tiago Fernandes, Vanesa Bijol, et al.. (2020). Impaired angiotensin II type 1 receptor signaling contributes to sepsis-induced acute kidney injury. Kidney International. 99(1). 148–160. 42 indexed citations

10.

Leisman, Daniel E., Fiore Mastroianni, Sareen Shah, et al.. (2020). Physiologic Response to Angiotensin II Treatment for Coronavirus Disease 2019–Induced Vasodilatory Shock: A Retrospective Matched Cohort Study. Critical Care Explorations. 2(10). e0230–e0230. 16 indexed citations

11.

Kelly, Alexander, Tiago Fernandes, Daniel E. Leisman, et al.. (2019). Use of Organ Dysfunction as a Primary Outcome Variable Following Cecal Ligation and Puncture: Recommendations for Future Studies. Shock. 54(2). 168–182. 4 indexed citations

12.

Angel, Cynthia, et al.. (2018). 379 Sepsis Presenting in Emergency Department Versus Inpatient Settings: Divergences in Prevalence, Patient Characteristics, Initial Resuscitation, Outcomes, and Costs. Annals of Emergency Medicine. 72(4). S149–S149. 1 indexed citations

13.

Leisman, Daniel E., Victor Huang, Qiuping Zhou, et al.. (2017). Delayed Second Dose Antibiotics for Patients Admitted From the Emergency Department With Sepsis: Prevalence, Risk Factors, and Outcomes*. Critical Care Medicine. 45(6). 956–965. 35 indexed citations

14.

Leisman, Daniel E., Jason A. D’Amore, Jeanie L. Gribben, et al.. (2017). Early sepsis bundle compliance for non-hypotensive patients with intermediate versus severe hyperlactemia. The American Journal of Emergency Medicine. 35(6). 811–818. 4 indexed citations

15.

Leisman, Daniel E., Martin E. Doerfler, Kevin D. Masick, et al.. (2017). Patterns and Outcomes Associated With Timeliness of Initial Crystalloid Resuscitation in a Prospective Sepsis and Septic Shock Cohort*. Critical Care Medicine. 45(10). 1596–1606. 51 indexed citations

16.

Leisman, Daniel E., Martin E. Doerfler, M.F. Ward, et al.. (2016). Survival Benefit and Cost Savings From Compliance With a Simplified 3-Hour Sepsis Bundle in a Series of Prospective, Multisite, Observational Cohorts. Critical Care Medicine. 45(3). 395–406. 79 indexed citations

17.

Sethna, Christine B. & Daniel E. Leisman. (2016). Left Ventricular Hypertrophy in Children with Hypertension: in Search of a Definition. Current Hypertension Reports. 18(8). 65–65. 11 indexed citations

18.

Sethna, Christine B., et al.. (2016). Acute Kidney Injury in Neonates in the PICU*. Pediatric Critical Care Medicine. 17(4). e159–e164. 21 indexed citations

19.

Leisman, Daniel E., et al.. (2014). Blood Pressure Variability in Children With Primary vs Secondary Hypertension. Journal of Clinical Hypertension. 16(6). 437–441. 10 indexed citations

20.

Bhatia, Jatinder, et al.. (2013). Concordance of Measures of Left-Ventricular Hypertrophy in Pediatric Hypertension. Pediatric Cardiology. 35(4). 622–626. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact